zidovudine and Epstein-Barr Virus Infections
zidovudine has been researched along with Epstein-Barr Virus Infections in 12 studies
Research
Studies (12)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Drosu, NC; Edelman, ER; Housman, DE | 1 |
Ashlock, B; Bayraktar, S; Bayraktar, UD; Cabral, L; Diaz, LA; Dittmer, DP; Pereira, D; Ramos, JC; Toomey, N | 1 |
Shah, I | 1 |
Baiocchi, RA; Barth, RF; Bhatt, D; Caligiuri, MA; Eisenbeis, CF; Ferketich, A; Grecula, J; Gupta, N; Moeschberger, M; Nuovo, GJ; Peng, R; Porcu, P; Roychowdhury, S; Schmalbrock, P; Vourganti, S; Yang, W | 1 |
Feuer, G; Harrington, W; Rochford, R; Toomey, L; Wu, W | 1 |
Barber, GN; Cabral, L; Dittmer, DP; Ghosh, SK; Harrington, WJ; Kurokawa, M; Mian, AM; Ramos, JC; Toomey, NL; Whitby, D | 1 |
Andela, V; Barreto, JE; Ghosh, S; Harrington, W; Kurokawa, M | 1 |
Li, xQ; Zhu, XZ | 1 |
Blackstock, W; Feng, W; Israel, B; Kenney, SC; Westphal, EM | 1 |
Carr, A; Cooper, DA; Cunningham, PH; Goh, LE; Grey, P; Kaufmann, GR; Smith, D; Suzuki, K; Zaunders, JJ | 1 |
Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C | 1 |
Reviews
1 review(s) available for zidovudine and Epstein-Barr Virus Infections
Article | Year |
---|---|
Zidovudine: a targeted therapy for endemic Burkitt's lymphoma.
Topics: Africa; Antiviral Agents; Brazil; Burkitt Lymphoma; Developing Countries; Drug Delivery Systems; Epstein-Barr Virus Infections; Gene Targeting; Herpesvirus 4, Human; Humans; Oncogenes; Zidovudine | 2005 |
Other Studies
11 other study(ies) available for zidovudine and Epstein-Barr Virus Infections
Article | Year |
---|---|
Could antiretrovirals be treating EBV in MS? A case report.
Topics: Adult; Brain; Drug Combinations; Epstein-Barr Virus Infections; Fatigue; Female; Humans; Immunologic Factors; Lamivudine; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors; Zidovudine | 2018 |
Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cell Line, Tumor; Combined Modality Therapy; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Remission Induction; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Zidovudine | 2014 |
Response to valacyclovir in an HIV-infected girl with Epstein Barr infection.
Topics: Acyclovir; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Child; Cyclopropanes; Epstein-Barr Virus Infections; Female; HIV Infections; Humans; Lamivudine; Valacyclovir; Valine; Zidovudine | 2012 |
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Topics: Animals; Antiviral Agents; Brain Neoplasms; Combined Modality Therapy; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Kidney Transplantation; Lymphoma, B-Cell; Male; Middle Aged; Rats; RNA, Messenger; Thymidine Kinase; Up-Regulation; Xenograft Model Antitumor Assays; Zidovudine | 2003 |
Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Interferon-alpha; Lymphoma, B-Cell; Membrane Glycoproteins; Mice; Mice, Inbred NOD; Mice, SCID; Reverse Transcriptase Inhibitors; Survival Rate; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Zidovudine | 2005 |
Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.
Topics: Apoptosis; Burkitt Lymphoma; Epstein-Barr Virus Infections; Gene Expression Profiling; Gene Expression Regulation, Viral; Genome, Viral; Herpesvirus 4, Human; Humans; Hydroxyurea; NF-kappa B; Phosphorylation; Reverse Transcriptase Inhibitors; Transcription Factor RelA; Tumor Cells, Cultured; Zidovudine | 2005 |
[Comment on pathology research of malignant lymphoma].
Topics: Antiviral Agents; Common Variable Immunodeficiency; Epstein-Barr Virus Infections; Humans; Interferon-alpha; Lymphoma; Pathology, Clinical; Prognosis; Zidovudine | 2006 |
Drug combination treats brain cancer.
Topics: Anti-HIV Agents; Brain Neoplasms; CD4 Lymphocyte Count; Drug Therapy, Combination; Epstein-Barr Virus Infections; Ganciclovir; HIV Infections; Humans; Interleukin-2; Lymphoma, AIDS-Related; Radiotherapy, Adjuvant; Treatment Outcome; Zidovudine | 1999 |
Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Topics: Animals; Antiviral Agents; B-Lymphocytes; Biotransformation; Burkitt Lymphoma; Butyrates; Cell Death; Cell Line, Transformed; Epstein-Barr Virus Infections; Ganciclovir; Herpesvirus 4, Human; Humans; Lymphocytes; Mice; Mice, SCID; Neoplasms, Experimental; Stomach Neoplasms; Tumor Virus Infections; Virus Activation; Xenograft Model Antitumor Assays; Zidovudine | 2000 |
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Epstein-Barr Virus Infections; Flow Cytometry; Furans; Genotype; HIV Infections; HIV-1; Humans; Immunoglobulin M; Lamivudine; Longitudinal Studies; Male; Proto-Oncogene Proteins c-bcl-2; Receptors, CCR5; Sulfonamides; Time Factors; Zidovudine | 2001 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine | 2001 |